2015-09-08 17:44:44 UTC

Ulcerative Colitis: There’s a Spice for That

Sept. 8, 2015

CGH research finds curcumin may improve patient response to mesalamine treatment.

For ulcerative colitis (UC) patients taking the anti-inflammatory agent mesalamine, there may be a way to improve treatment response. Recent research in Clinical Gastroenterology and Hepatology reports that adding curcumin — a spice in the ginger family — to oral and/or topical mesalamine makes the treatment more effective, putting more UC patients in remission.

The researchers performed a multicenter randomized, placebo-controlled, double-blind study of 50 mesalamine-treated patients with active mild-to-moderate ulcerative colitis who did not respond to an additional two weeks of the maximum dose of mesalamine oral and topical therapy.

The addition of curcumin to mesalamine therapy was superior to the combination of placebo and mesalamine at inducing clinical and endoscopic remission, and produced no apparent adverse effects. These findings suggest that curcumin may be a safe and promising agent for treatment of UC. 

Lead study author Nir Salomon shares insights on this research in a blog post on HealthCentral.

More on IBD

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Feb. 7, 2019

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.